Evidence map›Paper›PMID 42457925›Full record

ArticleCell death and differentiation2026

PAD4-generated citrullinated histones are triggers for autoinflammation in cryopyrin-associated periodic syndrome.

Bregje Christiaenssen, Silke Mortelmans, Siham Baghli, Fleur Boone, Wei Xie, Arinna Bertoni, My Ha, Benson Ogunjimi, Vito Sabato, Marco Gattorno and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Cell death and differentiation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Bregje ChristiaenssenCell Death Signaling Laboratory, Department of Biomedical Sciences, Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium.ORCID http://orcid.org/0000-0003-1011-6448
Silke MortelmansCell Death Signaling Laboratory, Department of Biomedical Sciences, Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium.ORCID http://orcid.org/0000-0002-1283-6054
Siham BaghliCell Death Signaling Laboratory, Department of Biomedical Sciences, Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium.
Fleur BooneVIB Center for Inflammation Research, VIB, Ghent, Belgium.ORCID http://orcid.org/0000-0002-6492-8401
Wei XieVIB Center for Inflammation Research, VIB, Ghent, Belgium.
Arinna BertoniUOC Reumatologia e Malattie Autoinfiammatorie, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
My HaAntwerp Center for Translational Immunology and Virology (ACTIV), Center for Health Economics Research and Modeling Infectious Diseases (CHERMID), Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Benson OgunjimiAntwerp Center for Translational Immunology and Virology (ACTIV), Center for Health Economics Research and Modeling Infectious Diseases (CHERMID), Vaccine and Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Vito SabatoDepartment of Immunology, Allergology, and Rheumatology, Antwerp University Hospital, Edegem, Belgium.
Marco GattornoUOC Reumatologia e Malattie Autoinfiammatorie, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Peter VandenabeeleVIB Center for Inflammation Research, VIB, Ghent, Belgium.ORCID http://orcid.org/0000-0002-6669-8822
Geert van LooVIB Center for Inflammation Research, VIB, Ghent, Belgium.ORCID http://orcid.org/0000-0002-8427-4775
Esther HosteVIB Center for Inflammation Research, VIB, Ghent, Belgium.ORCID http://orcid.org/0000-0002-3181-431X
Andy WullaertCell Death Signaling Laboratory, Department of Biomedical Sciences, Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium. andy.wullaert@uantwerpen.be.ORCID http://orcid.org/0000-0001-5012-654X

Funding

Bijzonder Onderzoeksfonds (Special Research Fund) 01IB3920Bijzonder Onderzoeksfonds (Special Research Fund) 01M00709Bijzonder Onderzoeksfonds (Special Research Fund) BOF23/GOA/001Bijzonder Onderzoeksfonds (Special Research Fund) IMPULSFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) 11P3Q24NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) 3G033120Fonds Wetenschappelijk Onderzoek (Research Foundation Flanders) 3G0A9322Fonds Wetenschappelijk Onderzoek (Research Foundation Flanders) 3G0AA824Fonds Wetenschappelijk Onderzoek (Research Foundation Flanders) 3G0I5722Fonds Wetenschappelijk Onderzoek (Research Foundation Flanders) EOS-G0H2522N-40007505Fonds Wetenschappelijk Onderzoek (Research Foundation Flanders) G071224NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) G0A3422NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) G0A7O24NFonds Wetenschappelijk Onderzoek (Research Foundation Flanders) S006425NStichting Tegen Kanker (Belgian Foundation Against Cancer) 365A08921Stichting Tegen Kanker (Belgian Foundation Against Cancer) 365G09122Stichting Tegen Kanker (Belgian Foundation Against Cancer) 365L04523
6 · The paper itself

Abstract

Cryopyrin-associated periodic syndromes (CAPS) are autoinflammatory disorders caused by gain-of-function NLRP3 variants. Although NLRP3 inflammasomes mediate IL-1β secretion through Gasdermin D (GSDMD), we show that GSDMD deletion did not prevent autoinflammation in mice ubiquitously expressing the Nlrp3

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.